BDBM350530 N-(4-bromophenyl)-2-(4-ethyl-2,5- dioxo-4-phenylimidazolidin-1- yl)acetamide::US10208071, Table 3.6::US10799518, Structure TABLE 3.6

SMILES CCC1(NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O)c1ccccc1

InChI Key InChIKey=KHDSTUZMHJIGKK-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350530   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350530(N-(4-bromophenyl)-2-(4-ethyl-2,5- dioxo-4-phenylim...)
Affinity DataEC50:  523nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350530(N-(4-bromophenyl)-2-(4-ethyl-2,5- dioxo-4-phenylim...)
Affinity DataEC50:  5.23E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent